AbbVie achieves 13 per cent reduction in absolute carbon emissions through technology and innovation
According to the World Health Organization1, climate change will have an overwhelmingly negative effect on human health globally. With the increase in deadly tropical and weather-related diseases, an increase in the demand for drugs and vaccines is expected. As this opens market for the pharma industries, it is important for the industry to grow their businesses sustainably by reducing their carbon emission from manufacturing sites.
AbbVie reaches over 2.3 million million people globally with their patient support programs
According to the World Health Organization (WHO), 71 million people are living with chronic hepatitis C virus 1 and around 38 million people are infected with HIV globally 2. Every year around 15 million premature babies are born worldwide 3. In this regard, AbbVie is continuing to invest in drug discovery and development. They have doubled their investment in R&D since its inception in 2013 to $5.1 billion in 2018 4;p5.
AbbVie sued by 635 victims in the US for severe birth defects linked to antiseizure drug Depakote
The pharmaceutical treatments help individuals to live extended, and better lives. At the same time, the pharma industry has a duty to the public to make safe products. According to a report, even properly prescribed drugs cause about 1.9 million hospitalizations a year 5.
AbbVie’s partnership with several community organizations strives to advance urban education in disenfranchised neighborhoods of Chicago.
The caliber of urban education in Chicago’s Public Schools (CPS) is often in a state of unrest. According to CPS, the majority of all 355,156 students are of either African-American (35.9%) or Hispanic (46.6%) descent1. Not only is the disparity of race among students clear, but also the confrontational relationship between the Chicago Teachers’ Union (CTU) and the city’s government over underfunding and underpayment2. At the end of 2019, these issues were brought to light as the city witnessed a “historic 11-day strike” to argue “that the era of public school disinvestment is ending in Chicago"3. This ongoing battle has weakened the reputation of public school education, however a number of community efforts between AbbVie and nonprofits in the city are championing education in diversified and impoverished communities in Chicago4.
Increase in the pricing of lifesaving medicines affects the patient’s affordability
Though pharmaceutical companies always play a vital role in sustaining research and development of new drugs, the costs for lifesaving drugs have skyrocketed in recent years.